Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1359

1.

[Safety of Dual Antiplatelet Therapy with Argatroban in Patients with Acute Ischemic Stroke].

Nagakane Y, Tanaka E, Ashida S, Kojima Y, Ogura S, Maezono K, Yamamoto Y.

Brain Nerve. 2018 May;70(5):557-562. doi: 10.11477/mf.1416201038. Japanese.

PMID:
29760293
2.

Evaluation of thrombin inhibitory activity of catechins by online capillary electrophoresis-based immobilized enzyme microreactor and molecular docking.

Li QQ, Yang FQ, Wang YZ, Wu ZY, Xia ZN, Chen H.

Talanta. 2018 Aug 1;185:16-22. doi: 10.1016/j.talanta.2018.03.049. Epub 2018 Mar 18.

PMID:
29759183
3.

Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.

Fu X, Ning JP.

J Mater Sci Mater Med. 2018 May 9;29(5):66. doi: 10.1007/s10856-018-6054-4.

PMID:
29744595
4.

Investigation of Interactions between Thrombin and Ten Phenolic Compounds by Affinity Capillary Electrophoresis and Molecular Docking.

Li QQ, Yang YX, Qv JW, Hu G, Hu YJ, Xia ZN, Yang FQ.

J Anal Methods Chem. 2018 Mar 20;2018:4707609. doi: 10.1155/2018/4707609. eCollection 2018.

5.

Novel degradation products of argatroban: Isolation, synthesis and extensive characterization using NMR and LC-PDA-MS/Q-TOF.

Guvvala V, Chidambaram Subramanian V, Anireddy JS, Konda M.

J Pharm Anal. 2018 Apr;8(2):86-95. doi: 10.1016/j.jpha.2017.07.001. Epub 2017 Jul 5.

6.

Argatroban is stable in citrated whole blood for 24 hours.

Guy S, Kitchen S, Van Veen JJ.

Int J Lab Hematol. 2018 Apr 29. doi: 10.1111/ijlh.12844. [Epub ahead of print]

PMID:
29707901
7.

Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.

Oguro H, Mitaki S, Takayoshi H, Abe S, Onoda K, Yamaguchi S.

J Stroke Cerebrovasc Dis. 2018 Apr 26. pii: S1052-3057(18)30169-1. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.016. [Epub ahead of print]

PMID:
29706441
8.

Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.

Peetermans M, Liesenborghs L, Peerlinck K, Wijngaerden EV, Gheysens O, Goffin KE, Hoylaerts MF, Jacquemin M, Verhaegen J, Peetermans WE, Verhamme P, Vanassche T; Staphylothrombin Investigators.

Thromb Haemost. 2018 Apr 3. doi: 10.1055/s-0038-1639586. [Epub ahead of print]

PMID:
29614521
9.

Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.

Abdillah JN, Hu Q, Chen X, Chen X, Zhou W, Luo W, Huang L.

Thorac Cardiovasc Surg. 2018 Apr 1. doi: 10.1055/s-0038-1637010. [Epub ahead of print]

PMID:
29605959
10.

Anticoagulation Management during First Five Days of Infant-Pediatric Extracorporeal Life Support.

Bingham KR, Riley JB, Schears GJ.

J Extra Corpor Technol. 2018 Mar;50(1):30-37.

PMID:
29559752
11.

Esophageal submucosal hematoma developed after endovascular surgery for unruptured cerebral aneurysm under general anesthesia: a case report.

Ito S, Iwata S, Kondo I, Iwade M, Ozaki M, Ishikawa T, Kawamata T.

JA Clin Rep. 2017;3(1):54. doi: 10.1186/s40981-017-0124-3. Epub 2017 Oct 3.

12.

Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.

Beiderlinden M, Werner P, Bahlmann A, Kemper J, Brezina T, Schäfer M, Görlinger K, Seidel H, Kienbaum P, Treschan TA.

BMC Anesthesiol. 2018 Feb 9;18(1):18. doi: 10.1186/s12871-018-0475-y.

13.

Heparin-Induced Thrombocytopenia during Obstetric Hospital Admissions.

Sagaram D, Siddiq Z, Eisenberger AB, Ananth CV, Wright JD, D'Alton ME, Friedman AM.

Am J Perinatol. 2018 Feb 8. doi: 10.1055/s-0038-1627096. [Epub ahead of print]

PMID:
29421832
14.

Argatroban dosing in obesity.

Elagizi S, Davis K.

Thromb Res. 2018 Mar;163:60-63. doi: 10.1016/j.thromres.2018.01.011. Epub 2018 Jan 9.

PMID:
29367082
15.

Phenolic fractions from nine Trifolium species modulate the coagulant properties of blood plasma in vitro without cytotoxicity towards blood cells.

Kolodziejczyk-Czepas J, Sieradzka M, Moniuszko-Szajwaj B, Nowak P, Oleszek W, Stochmal A.

J Pharm Pharmacol. 2018 Mar;70(3):413-425. doi: 10.1111/jphp.12872. Epub 2018 Jan 17.

PMID:
29341135
16.

Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients.

Nakase T, Moroi J, Ishikawa T.

Clin Transl Med. 2018 Jan 12;7(1):2. doi: 10.1186/s40169-017-0179-9.

17.

The Prevalence of Adverse Ocular Hemorrhagic Events in Patients Utilizing Oral Anticoagulant and Antiplatelet Therapy in Routine Clinical Practice.

Sudarshana DM, Konstantinou EK, Arepalli S, Silva FQ, Schachat AP, Ehlers JP, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):27-34. doi: 10.3928/23258160-20171215-04.

PMID:
29304263
18.

Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery.

Koster A, Faraoni D, Levy JH.

Anesthesiology. 2018 Feb;128(2):390-400. doi: 10.1097/ALN.0000000000001976. Review. No abstract available.

PMID:
29206646
19.

Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.

Tsujita R, Tsubota M, Hayashi Y, Saeki H, Sekiguchi F, Kawabata A.

J Neuroimmune Pharmacol. 2018 Jun;13(2):179-188. doi: 10.1007/s11481-017-9773-2. Epub 2017 Dec 1.

PMID:
29196860
20.

Anticoagulation Therapies in Children.

Young G.

Pediatr Clin North Am. 2017 Dec;64(6):1257-1269. doi: 10.1016/j.pcl.2017.08.004. Epub 2017 Oct 4. Review.

PMID:
29173784

Supplemental Content

Loading ...
Support Center